Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous Urticaria
Clinical trial NCT04944602 · UNKNOWN
Trial details
- NCT number
- NCT04944602
- Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2023-03-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.